Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2006 3
2007 2
2009 8
2010 8
2011 7
2012 3
2013 8
2014 8
2015 2
2016 2
2017 5
2018 4
2019 3
2020 6
2021 7
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Circulating Oxalate Levels in Short Bowel Syndrome as a Severity Marker of CKD.
Grocholski C, Chambrier C, Lauverjat M, Acquaviva C, Abid N, Bergoin C, Guebre-Egziabher F, Bacchetta J, Derain-Dubourg L, De Mul A, Lemoine S. Grocholski C, et al. Among authors: guebre egziabher f. Kidney Int Rep. 2023 Dec 28;9(3):686-693. doi: 10.1016/j.ekir.2023.12.023. eCollection 2024 Mar. Kidney Int Rep. 2023. PMID: 38481504 Free PMC article.
[Oxalate: from physiology to pathology].
Grocholski C, Derain Dubourg L, Guebre-Egziabher F, Acquaviva-Bourdain C, Abid N, Bacchetta J, Chambrier C, Lemoine S. Grocholski C, et al. Among authors: guebre egziabher f. Nephrol Ther. 2023 Jun 19;19(3):201-214. doi: 10.1684/ndt.2023.10. Nephrol Ther. 2023. PMID: 37166780 Review. French.
Mild Therapeutic Hypothermia Protects from Acute and Chronic Renal Ischemia-Reperfusion Injury in Mice by Mitigated Mitochondrial Dysfunction and Modulation of Local and Systemic Inflammation.
Schleef M, Gonnot F, Pillot B, Leon C, Chanon S, Vieille-Marchiset A, Rabeyrin M, Bidaux G, Guebre-Egziabher F, Juillard L, Baetz D, Lemoine S. Schleef M, et al. Among authors: guebre egziabher f. Int J Mol Sci. 2022 Aug 17;23(16):9229. doi: 10.3390/ijms23169229. Int J Mol Sci. 2022. PMID: 36012493 Free PMC article.
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Michael M, Groothoff JW, Shasha-Lavsky H, Lieske JC, Frishberg Y, Simkova E, Sellier-Leclerc AL, Devresse A, Guebre-Egziabher F, Bakkaloglu SA, Mourani C, Saqan R, Singer R, Willey R, Habtemariam B, Gansner JM, Bhan I, McGregor T, Magen D. Michael M, et al. Among authors: guebre egziabher f. Am J Kidney Dis. 2023 Feb;81(2):145-155.e1. doi: 10.1053/j.ajkd.2022.05.012. Epub 2022 Jul 14. Am J Kidney Dis. 2023. PMID: 35843439 Free article. Clinical Trial.
Assessing Global Kidney Nutrition Care.
Wang AY, Okpechi IG, Ye F, Kovesdy CP, Brunori G, Burrowes JD, Campbell K, Damster S, Fouque D, Friedman AN, Garibotto G, Guebre-Egziabher F, Harris D, Iseki K, Jha V, Jindal K, Kalantar-Zadeh K, Kistler B, Kopple JD, Kuhlmann M, Lunney M, Mafra D, Malik C, Moore LW, Price SR, Steiber A, Wanner C, Ter Wee P, Levin A, Johnson DW, Bello AK. Wang AY, et al. Among authors: guebre egziabher f. Clin J Am Soc Nephrol. 2022 Jan;17(1):38-52. doi: 10.2215/CJN.07800621. Epub 2022 Jan 3. Clin J Am Soc Nephrol. 2022. PMID: 34980675 Free PMC article.
79 results